Dayle, Evanah .

HRN: 28-56-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CEFUROXIME 1.5GM (VIAL)
02/18/2026
02/24/2026
IV
350mg
Q8
SVI; T/C UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines